Aebersold DM - Search Results

1

Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10.

Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller AC, Plasswilm L, Papachristofilou A, Stalder L, Biaggi-Rudolf C, Sumila M, Kranzbühler H, Najafi Y, Ost P, Azinwi NC, Reuter C, Bodis S, Kaouthar K, Wust P, Thalmann GN, Aebersold DM. Ghadjar P, et al. Among authors: aebersold dm. J Clin Oncol. 2015 Dec 10;33(35):4158-66. doi: 10.1200/JCO.2015.63.3529. Epub 2015 Nov 2. J Clin Oncol. 2015. PMID: 26527774 Clinical Trial.

2

Applicability and dosimetric impact of ultrasound-based preplanning in high-dose-rate brachytherapy of prostate cancer.

Aebersold DM, Isaak B, Thalmann G, Behrensmeier F, Kolotas C, Kranzbühler H, Mini R, Greiner RH. Aebersold DM, et al. Strahlenther Onkol. 2004 Jun;180(6):351-7. doi: 10.1007/s00066-004-1225-2. Strahlenther Onkol. 2004. PMID: 15175869 Clinical Trial.

3

Daily organ tracking in intensity-modulated radiotherapy of prostate cancer using an electronic portal imaging device with a dose saving acquisition mode.

Vetterli D, Thalmann S, Behrensmeier F, Kemmerling L, Born EJ, Mini R, Greiner RH, Aebersold DM. Vetterli D, et al. Among authors: aebersold dm. Radiother Oncol. 2006 Apr;79(1):101-8. doi: 10.1016/j.radonc.2006.03.005. Epub 2006 Apr 18. Radiother Oncol. 2006. PMID: 16621076

4

Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking.

Ghadjar P, Vock J, Vetterli D, Manser P, Bigler R, Tille J, Madlung A, Behrensmeier F, Mini R, Aebersold DM. Ghadjar P, et al. Among authors: aebersold dm. Radiat Oncol. 2008 Oct 20;3:35. doi: 10.1186/1748-717X-3-35. Radiat Oncol. 2008. PMID: 18937833 Free PMC article.

5

Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy.

Ghadjar P, Keller T, Rentsch CA, Isaak B, Behrensmeier F, Stroux A, Thalmann GN, Aebersold DM. Ghadjar P, et al. Among authors: aebersold dm. Brachytherapy. 2009 Jan-Mar;8(1):45-51. doi: 10.1016/j.brachy.2008.09.004. Epub 2008 Nov 26. Brachytherapy. 2009. PMID: 19038584

6

Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer.

Ghadjar P, Matzinger O, Isaak B, Behrensmeier F, Stroux A, Rentsch CA, Thalmann GN, Aebersold DM. Ghadjar P, et al. Among authors: aebersold dm. Radiother Oncol. 2009 May;91(2):237-42. doi: 10.1016/j.radonc.2008.12.007. Epub 2009 Jan 21. Radiother Oncol. 2009. PMID: 19167121

7

The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer.

Ghadjar P, Rubie C, Aebersold DM, Keilholz U. Ghadjar P, et al. Among authors: aebersold dm. Int J Cancer. 2009 Aug 15;125(4):741-5. doi: 10.1002/ijc.24468. Int J Cancer. 2009. PMID: 19480006 Free article. Review.

8

MET Y1253D-activating point mutation and development of distant metastasis in advanced head and neck cancers.

Ghadjar P, Blank-Liss W, Simcock M, Hegyi I, Beer KT, Moch H, Aebersold DM, Zimmer Y. Ghadjar P, et al. Among authors: aebersold dm. Clin Exp Metastasis. 2009;26(7):809-15. doi: 10.1007/s10585-009-9280-9. Epub 2009 Jul 29. Clin Exp Metastasis. 2009. PMID: 19639388 Free article.

9

Quantitative analysis of extracapsular extension of metastatic lymph nodes and its significance in radiotherapy planning in head and neck squamous cell carcinoma.

Ghadjar P, Schreiber-Facklam H, Gräter R, Evers C, Simcock M, Geretschläger A, Blumstein NM, Zbären P, Zimmer Y, Wilkens L, Aebersold DM. Ghadjar P, et al. Among authors: aebersold dm. Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1127-32. doi: 10.1016/j.ijrobp.2009.03.065. Epub 2009 Aug 3. Int J Radiat Oncol Biol Phys. 2010. PMID: 19647955

10

Use of gold markers for setup in image-guided fractionated high-dose-rate brachytherapy as a monotherapy for prostate cancer.

Ghadjar P, Gwerder N, Madlung A, Behrensmeier F, Thalmann GN, Mini R, Aebersold DM. Ghadjar P, et al. Among authors: aebersold dm. Strahlenther Onkol. 2009 Nov;185(11):731-5. doi: 10.1007/s00066-009-2007-7. Epub 2009 Nov 10. Strahlenther Onkol. 2009. PMID: 19899006 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

215 results

Search Page